| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $100.4M | +9.7% |
| Cost of Revenue | $2.1M | +21.6% |
| R&D Expense | $230.8M | -7.2% |
| SG&A Expense | $69.4M | -12.6% |
| Operating Income | -$237.6M | +9.7% |
| Pre-tax Income | -$217.6M | +14.4% |
| Income Tax | $0 | — |
| Net Income | -$217.6M | +14.4% |
| EPS (Basic) | -$4.42 | +38.0% |
| EPS (Diluted) | -$4.42 | +38.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.0M | +5.5% |
| Accounts Receivable | $13.4M | -36.0% |
| Current Assets | $237.8M | -21.0% |
| Total Assets | $565.4M | -13.9% |
| Current Liabilities | $59.8M | -25.1% |
| Total Liabilities | $310.1M | -10.4% |
| Stockholders' Equity | $255.3M | -17.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.9M | +29.6% |
| Capital Expenditures | $13.9M | -39.3% |
| Investing Cash Flow | $43.9M | +275.0% |
| Financing Cash Flow | $127.4M | -23.4% |
| Free Cash Flow | -$180.7M | +30.5% |